Robert Oberlender

Robert Arthur Oberlender
Born (1956-07-25) July 25, 1956
Philadelphia, Pennsylvania
Alma materTemple University (B.S.), Purdue University (Ph.D.)
OccupationsMedicinal chemist; Assistant professor
Years active1984–present
Organization(s)Purdue University (1981–1995); University of the Pacific; New River Pharmaceuticals (2000–2007); Synthonics (2007–)
Known forWork in the area of serotonergic and dopaminergic drugs, discovery and development of lisdexamfetamine (Vyvanse)

Robert Arthur Oberlender (born July 25, 1956) is an American medicinal chemist known for his work in the areas of serotonergic and dopaminergic drugs as well as drug discrimination. He is most well known for his discovery and development of lisdexamfetamine (lysine–dextroamphetamine), which is now marketed as a pharmaceutical drug under the brand name Vyvanse and is prescribed as a misuse-resistant stimulant in the treatment of attention deficit hyperactivity disorder (ADHD) and other conditions.

This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.